Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of the cell division-associated peptidoglycan amidase AmiA of <i>Chlamydia trachomatis</i>.

Journal of bacteriology·2026
Same author

From commitment to action: lessons from 18 transdisciplinary projects addressing health risks in wildlife trade.

One health outlook·2026
Same author

<i>Chlamydia trachomatis</i> restricts signaling through NOD2 until late in the pathogen's developmental cycle.

Infection and immunity·2025
Same author

Characterization of the Cell Division-Associated Peptidoglycan Amidase AmiA of <i>Chlamydia trachomatis</i>.

bioRxiv : the preprint server for biology·2025
Same author

Chlamydia trachomatis restricts signaling through NOD2 until late in the pathogen's developmental cycle.

bioRxiv : the preprint server for biology·2025
Same author

The Dual Mode of Antibacterial Action of the Synthetic Small Molecule DCAP Involves Lipid II Binding.

Journal of the American Chemical Society·2024
Same journal

[In process].

Medizinische Monatsschrift fur Pharmazeuten·2018
Same journal

[In process].

Medizinische Monatsschrift fur Pharmazeuten·2018
Same journal

[In process].

Medizinische Monatsschrift fur Pharmazeuten·2018
Same journal

[In process].

Medizinische Monatsschrift fur Pharmazeuten·2018
Same journal

[In process].

Medizinische Monatsschrift fur Pharmazeuten·2018
Same journal

[In process].

Medizinische Monatsschrift fur Pharmazeuten·2018
See all related articles

Related Experiment Video

Updated: May 20, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

[Infections with Chlamydia trachomatis].

Ingo Stock1, Beate Henrichfreise

  • 1Institut für Medizinische Mikrobiologie, Immunologie und Parasitologie, Abteilung Pharmazeutische Mikrobiologie, Universität Bonn, Meckenheimer Allee 168, 53115 Bonn. Ingo_Stock@web.de

Medizinische Monatsschrift Fur Pharmazeuten
|July 20, 2012
PubMed
Summary
This summary is machine-generated.

Chlamydia trachomatis causes sexually transmitted infections and trachoma, a leading cause of blindness. Effective treatment involves antibiotics like azithromycin, with screening and the SAFE strategy aiding elimination efforts.

More Related Videos

Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells
07:42

Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells

Published on: October 13, 2015

Related Experiment Videos

Last Updated: May 20, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells
07:42

Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells

Published on: October 13, 2015

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Context:

  • Chlamydia trachomatis is a leading cause of sexually transmitted infections globally.
  • It causes a spectrum of diseases, including urogenital infections, pelvic inflammatory disease, and trachoma.
  • Serovars D-K cause urogenital infections, L1-L3 cause lymphogranuloma venereum, and A-C cause trachoma.

Purpose:

  • To provide a comprehensive overview of Chlamydia trachomatis infections.
  • To discuss the clinical manifestations, transmission, and treatment of C. trachomatis.
  • To highlight the public health implications and control strategies for C. trachomatis.

Summary:

  • C. trachomatis infections manifest as urogenital diseases, potentially leading to infertility and ectopic pregnancy, or as trachoma, a leading cause of preventable blindness.
  • Treatment relies on intracellularly acting antibiotics such as doxycycline, macrolides (azithromycin, erythromycin), and quinolones (levofloxacin, ofloxacin).
  • Pregnancy management involves macrolides or aminopenicillins, while C. trachomatis screening and the WHO's SAFE strategy are crucial for disease control and elimination.

Impact:

  • Effective antibiotic treatment and public health interventions like screening and the SAFE strategy are vital for managing C. trachomatis infections.
  • Early diagnosis and treatment can prevent severe complications such as infertility and blindness.
  • Global efforts aim to eliminate trachoma, a major cause of blindness, by 2020 through integrated therapeutic and hygienic measures.